Zhao et al. indicated that TFAP2A-AS1 was significantly associated with overall survival in bladder cancer patients, and TFAP2A-AS1 was a protective factor against bladder cancer [11]. This evidence concerns the gene TFAP2A and urinary bladder carcinoma.